UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006723
Receipt number R000007940
Scientific Title Clinical research of bone marrow-derived mesenchymal stem cell transplantation for the patients with epidermolysis bullosa.
Date of disclosure of the study information 2011/11/14
Last modified on 2019/11/20 10:28:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical research of bone marrow-derived mesenchymal stem cell transplantation for the patients with epidermolysis bullosa.

Acronym

Clinical research of bone marrow-derived mesenchymal stem cell transplantation for the patients with epidermolysis bullosa.

Scientific Title

Clinical research of bone marrow-derived mesenchymal stem cell transplantation for the patients with epidermolysis bullosa.

Scientific Title:Acronym

Clinical research of bone marrow-derived mesenchymal stem cell transplantation for the patients with epidermolysis bullosa.

Region

Japan


Condition

Condition

Epidermolysis bullosa (junctional, dystrophic)

Classification by specialty

Hematology and clinical oncology Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of safety and efficacy of family donor-derived bone marrow mesenchymal stem cell transplantation to the patients with junctional and dystrophic epidermolysis bullosa.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety evaluation
(Adverse events)

Key secondary outcomes

Efficacy evaluation
(macroscopic and histological examination of the skin lesions)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Subcutaneous transplantation of bone marrow mesenchymal stem cells

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients diagnosed with epidermolysis bullosa (junctional or dystrophic type).
2) Patients aged 20-60 years old.
3) Patients with intractable skin ulcer which present for more than 6 weeks.
4) Patients who have opposite-sex parent or sibling with donor agreement.
5) Patients who agreed with written concent

Key exclusion criteria

1) Patients with severe psychotic disorders
2) Patients with alcoholic addiction
3) Patients with disturbance of consciousness
4) Patients with history of malignancy within the last 5 years
5) Patients with pregnancy
6) Patients with diabetes

Other patients who are evaluated not to be suitable for this research

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Katsuto Tamai

Organization

Osaka University Graduate School of Medicine

Division name

Department of Stem Cell Therapy Science

Zip code


Address

2-2, Yamadaoka, Suita-shi, Osaka 565-0871, Japan

TEL

06-6879-3902

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Osaka University Hospital

Division name

Medical Center for Translational Research

Zip code


Address

2-15, Yamadaoka, Suita-shi, Osaka 565-0871, Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Osaka University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院(大阪府)/Osaka University Hospital (Osaka)


Other administrative information

Date of disclosure of the study information

2011 Year 11 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 10 Month 14 Day

Date of IRB

2013 Year 04 Month 03 Day

Anticipated trial start date

2013 Year 07 Month 26 Day

Last follow-up date

2015 Year 05 Month 01 Day

Date of closure to data entry

2015 Year 05 Month 01 Day

Date trial data considered complete

2017 Year 02 Month 02 Day

Date analysis concluded

2017 Year 02 Month 02 Day


Other

Other related information



Management information

Registered date

2011 Year 11 Month 14 Day

Last modified on

2019 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007940


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name